These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 51964)

  • 1. Comparison of 5-day, 1-day, and 2-day cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Bates TD; Brinkley D; MacRae KD; Spittle MF; Wheeler T
    Lancet; 1975 Aug; 2(7927):209-11. PubMed ID: 51964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-day and 2-day cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Bates TD; Brinkley D; MacRae KD; Spittle MF; Wheeler T
    Clin Oncol; 1979 Jun; 5(2):163-7. PubMed ID: 466894
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
    Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
    Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced breast cancer: are the traditional stratification parameters still of value when patients are treated with combination chemotherapy?
    Valagussa P; Brambilla C; Bonadonna G
    Eur J Cancer (1965); 1979 Apr; 15(4):565-71. PubMed ID: 374086
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy.
    Chlebowski RT; Irwin LE; Pugh RP; Sadoff L; Hestorff R; Wiener JM; Bateman JR
    Cancer Res; 1979 Nov; 39(11):4503-6. PubMed ID: 387216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for metastatic breast cancer.
    Mayer EL; Burstein HJ
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):257-72. PubMed ID: 17512448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer.
    Vogel CL; Love NH; East DR; Moore MR; Smalley RV
    Cancer Treat Rep; 1979; 63(11-12):2077-9. PubMed ID: 526940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of complete response to chemotherapy in advanced breast cancer.
    Fischer J; Rose CJ; Rubens RD
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):747-54. PubMed ID: 6759140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in advanced breast cancer: experience in 100 cases (author's transl)].
    Modolell Roig A; Sans-Sabrafen J; Pardo Peret P; Rodríguez Ferrera JC; Boleda Relats M; Buxó Costa J; Galofré Folch M
    Med Clin (Barc); 1982 Mar; 78(6):211-7. PubMed ID: 7087579
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for advanced male breast cancer.
    Yap HY; Tashima CK; Blumenschein GR; Hortobagyi GN; Eckles N
    JAMA; 1980 May; 243(17):1739-41. PubMed ID: 7365938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey D; Gelman R; Falkson G
    Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a fixed alternating treatment in patients with advanced breast cancer.
    Ahmann DL; O'Fallon J; O'Connell MJ; Bisel HF; Hahn RG; Frytak S; Edmonson JH; Rubin J; Ingle JN; Kvols LK
    Cancer Clin Trials; 1978; 1(3):219-26. PubMed ID: 391427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.
    Cavalli F; Goldhirsch A; Jungi F; Martz G; MermillodB ; Alberto P
    J Clin Oncol; 1984 May; 2(5):414-9. PubMed ID: 6233398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 17. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel: new preparation. No first-line use in metastatic breast cancer.
    Prescrire Int; 2001 Dec; 10(56):178-9. PubMed ID: 11824441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE; Nagel GA
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical sequential hormonochemotherapy in advanced breast cancer.
    Ghilchik MW; Shaikh NA; Beranek PA; Reed MJ
    Br Med J (Clin Res Ed); 1987 Nov; 295(6607):1172. PubMed ID: 3120930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.